Novartis gene therapy set to enhance SMA treatment - PharmaTimes OAV101 IT expands potential for type II SMA patients

@novartis.bsky.social #genetherapy #spinalmuscularatrophy #SMAtreatment #OAV101IT #onasemnogeneabeparvovec #typeIISMApatients #intrathecalformaulation #STEERstudy #genetransfertherapy #typeIIspinalmuscularatrophy #SMAawareness #Zolgensma #IVformulation #Neurology
pharmatimes.com/news/novarti...